3878
M. R. Atuu, M. M. Hossain / Tetrahedron Letters 48 (2007) 3875–3878
derivatives 2b–h6 were subjected to the DKR reaction
conditions in order to investigate the scope of this pro-
cess (Table 1). In all cases, racemic substrates 2b–h were
completely consumed, and chiral products were isolated
in good to high yields (Table 1). In addition, the enantio-
selectivities for the product were generally high and
similar to those reported from our kinetic resolution
process.6
7. (a) Serra, S.; Brenna, E.; Fuganti, C.; Maggioni, F.
Tetrahedron: Asymmetry 2003, 14, 3313; (b) Kawanami,
Y.; Itoh, K. Chem. Lett. 2005, 34, 682; (c) Ferraboschi, P.;
Rezaelahi, S.; Verza, E.; Santaniello, E. Tetrahedron:
Asymmetry 1998, 9, 2193; (d) Balint, J.; Kiss, V.; Egri, G.;
Kalai, T.; Demeter, A.; Balog, M.; Fogassy, E.; Hideg, K.
Tetrahedron: Asymmetry 2004, 15, 671; (e) Morrone, R.;
Piatttelli, M.; Nocolosi, G. Eur. J. Org. Chem. 2001, 1444;
(f) Levy, L. M.; Dehli, J. R.; Gotor, V. Tetrahedron:
Asymmetry 2003, 14, 2053.
It is noteworthy to mention that our process is simple;
no external hydrogen source is needed for very good
to excellent yields and ee %. In most DKR methods
involving chiral secondary alcohols, an external hydro-
gen source is used to enhance yields and enantioselecti-
vies.10,12 In addition, most of these the DKR proceses
were carried out at higher temperatures (60–80 ꢁC) to
speed up the racemization step.10,12 Our DKR process
eliminates the need for an external hydrogen source or
higher temperature to obtain very good yields of prod-
ucts. One reason for the overall simplicity of our
DKR process may lie in the use of a more reactive pri-
mary alcohol (easier to dehydrogenate than secondary
alcohol) and formation of an aldehyde (easier to hydro-
genate than ketone). Further studies using different
hydrogen donors at different temperatures in order to
optimize yields and enatioselectivities of this DKR pro-
cess are underway.
8. (a) Kiebasinski, P.; Omelanczuk, J.; Mikolaczyk, M.
˜
Tetrahedron: Asymmetry 1998, 9, 3283; (b) Kagan, H.
B.; Fiaud, J. C. Top. Stereochem. 1988, 18, 249; (c) Keith,
J. M.; Larrow, J. F.; Jacobsen, E. N. Adv. Synth. Catal.
2001, 343, 5; (d) Choi, Y.-K.; Kim, Y. H.; Nam, S. H.;
Shin, S. T.; Kim, M.-J.; Park, J. Angew. Chem., Int. Ed.
2002, 41, 2373; (e) Choi, Y. K.; Suh, J. H.; Lee, D.; Lim, I.
T.; Jung, J. Y.; Kim, M. J. J. Org. Chem. 1999, 64, 8423;
(f) Morgan, B.; Bydlinky, G.; Dodds, D. R. Tetrahedron:
Asymmetry 1995, 6, 1765; (g) Persson, B. A.; Larsson, A.
L. E.; Ray, M. L.; Ba¨ckvall, J.-E. J. Org. Chem. 1999, 121,
1645; (h) Kirchner, G.; Scollar, M. P.; Klibanov, A. M. J.
Am. Chem. Soc. 1985, 107, 7072; (i) Strauss, U. T.; Felfer,
U.; Faber, K. Tetrahedron: Asymmetry 1999, 10, 107.
`
9. (a) Pamies, O.; Ba¨ckvall, J.-E. J. Org. Chem. 2002, 10, 1021;
(b) Koh, H. J.; Jeong, H. M.; Park, J. Tetrahedron Lett.
1998, 39, 5545; (c) Garcia, M.; del Campo, C.; Llama, E. F.;
Sanchez-Montero, J. M.; Sinisterra, J. V. Tetrahedron 1993,
49, 8433; (d) Lee, D.; Huh, E. A.; Kim, M.-J.; Park, J. Org.
Lett. 2000, 2, 2377; (e) Huerta, F.; Ba¨ckvall, J.-E. Org. Lett.
2001, 3, 1209; (f) Chowdbury, R. L.; Ba¨ckvall, J.-E. Chem.
Commun. 1991, 1063.
In conclusion, we have demonstrated that a ruthenium
catalyst in combination with enzymatic acylation, re-
sults in racemization and a full transformation of tropic
acid ester (primary alcohol) 2a–i to 3-acetoxy-2-phenyl
propionic acid ethyl ester 3a–i in good yield and good
% ee. Currently, we are working to convert these chiral
3-acetoxy-2-phenyl propionic acid esters into chiral 2-
aryl propionic acids. Many of these chiral 2-aryl propa-
noic acids such as ibuprofen and naproxen are impor-
tant non-steroidal anti-inflamatory drugs (NSAIDs).16
10. (a) Almeida, M. L. S.; Kocovsky, P.; Ba¨ckvall, J.-E. J.
`
Org. Chem. 1996, 61, 6587; (b) Pamies, O.; Ba¨ckvall, J.-E.
`
Trends Biotechnol. 2004, 22, 130; (c) Pamies, O.; Ba¨ckvall,
J.-E. J. Org. Chem. 2002, 67, 1261; (d) Larsson, A. L. E.;
Persson, B. A.; Ray, M. L.; Ba¨ckvall, J.-E. Angew. Chem.,
`
Int. Ed. 1997, 36, 1211; (e) Pamies, O.; Ba¨ckvall, J.-E. J.
Org. Chem. 2002, 67, 9006; (f) Jung, H. M.; Koh, J. H.;
Kim, M.-J.; Park, J. Org. Lett. 2000, 2, 2487.
11. (a) Sorgedrager, M. J.; Malpique, R.; Rantwijk, F. V.;
Sheldon, R. Tetrahedron: Asymmetry 2004, 15, 1295; (b)
Ji, A.; Wolberg, M.; Hummel, W.; Wandrey, C.; Muller,
M. Chem. Commun. 2001, 57.
12. (a) Shvo, Y.; Czarkie, D.; Rahamin, Y.; Chodosh, D. F.
J. Am. Chem. Soc. 1986, 108, 7400; (b) Menashe, N.;
Shvo, Y. Organometallics 1991, 10, 3885; (c) Kim, M. J.;
Choi, Y. K.; Choi, M. Y.; Park, J. J. Org. Chem. 2001, 66,
4736; (d) Riermeier, T. H.; Gross, P.; Monsees, A.;
Hoff, M.; Trauthwein, H. Tetrahedron Lett. 2005, 46,
3403.
Acknowledgement
Thanks to Amano company for providing us with
enzymes lipases PS.
13. Casey, C. P.; Singer, S. W.; Powell, D. R.; Hayashi, R. K.;
Kavana, M. J. Am. Chem. Soc. 2001, 123, 1090.
14. (a) Veum, L.; Hanefeld, U. Tetrahedron: Asymmetry 2004,
15, 3707; (b) Chen, C. S.; Sih, C. J. Angew. Chem., Int. Ed.
Engl. 1989, 28, 695; (c) Wang, Y. W.; Lalonde, J. J.;
Momongan, M.; Bergbreiter, D. E.; Wong, C.-H. J. Am.
Chem. Soc. 1988, 110, 7200.
References and notes
1. (a) Leete, E. J. Am. Chem. Soc. 1960, 82, 612; (b) Hamon,
N. W.; Eyolfson, J. L. J. Pharm. Sci. 1972, 61, 2006; (c)
Leete, E.; Kowanko, N.; Newmark, A. R. J. Am. Chem.
Soc. 1975, 97, 6826.
15. (a) Verzijl, G. K. M.; de Vries, J. G.; Broxterman, Q. B.
Tetrahedron: Asymmetry 2005, 16, 1603; (b) Choi, J. H.;
Kim, M.-J.; Nam, S. H.; Shin, S. T.; Kim, Y. H.; Park, J.
Angew. Chem., Int. Ed. 2002, 41, 2373.
16. (a) Sehgal, A. C.; Kelly, R. M. Biotechnol. Prog. 2003, 19,
1410; (b) Chang, C.-S.; Tsai, S.-W.; Lin, C.-N. Tetrahe-
dron: Asymmetry 1998, 9, 2799; (c) Kumar, I.; Manju, K.;
Jolly, R. S. Tetrahedron: Asymmetry 2001, 12, 1431; (d)
Giordano, C.; Castaldi, G.; Uggeri, F. A. Angew. Chem.,
Int. Ed. Engl. 1984, 23, 413; (e) Shen, T. Y. Angew. Chem.,
Int. Ed. Engl. 1972, 11, 460.
2. Glasby, J. S. In Encyclopedia of the Alkaloids; Plenum:
New York, 1975; Vol. 1, p 731.
3. (a) Conklin, M. E. In Genetic and Biochemical Aspects of
the Development of Datura; Karger S: London, 1976; Vols.
1–3, p 118; (b) Roberts, M. F.; Wink, M. In Alkaloids:
Biochemistry, Ecology and Medicinal Applications; Ple-
num: New York, 1998; Vol. 117, p 145.
4. Physician’s Desk Reference, 56th ed.; 2002; p 1993.
5. Physician’s Desk Reference, 56th ed.; 2002; p 1030.
6. Atuu, M. R.; Mahmood, S. J.; Laib, F.; Hossain, M. M.
Tetrahedron: Asymmetry 2004, 15, 3091.